Cargando…

The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial

OBJECTIVES: Psoriasis is a chronic inflammatory disease showing co-existence with metabolic syndrome (MS), as has been confirmed by numerous epidemiologic studies in recent times. In this study, the aim was to ascertain the beneficial effects of pioglitazone in psoriasis, simultaneously targeting th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abidi, Afroz, Rizvi, Dilshad Ali, Saxena, Kshitij, Chaudhary, Savita, Ahmad, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074427/ https://www.ncbi.nlm.nih.gov/pubmed/32201442 http://dx.doi.org/10.4103/ijp.IJP_88_19

Ejemplares similares

The efficacy and safety of pioglitazone in psoriasis vulgaris: A meta-analysis of randomized controlled trials
por: Chen, Pengfei, et al.
Publicado: (2020)

Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
por: West, Jonathan, et al.
Publicado: (2016)

Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
por: Kim, Jeong Mi, et al.
Publicado: (2020)

Correction: Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
Publicado: (2016)

Effectiveness and safety of different doses of pioglitazone in psoriasis: a meta-analysis of randomized controlled trials
por: Zhang, Jing-Zhan, et al.
Publicado: (2020)

Efficacy of Methotrexate in patients with plaque type psoriasis
por: Haider, Sabiqa, et al.
Publicado: (2014)

Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability
por: Manalo, Iviensan F, et al.
Publicado: (2015)

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study
por: Erande, Suhas, et al.
Publicado: (2023)

A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment
por: Reich, K., et al.
Publicado: (2019)

Pioglitazone in the Treatment of Type 2 Diabetes: Safety and Efficacy Review
por: Desouza, Cyrus V., et al.
Publicado: (2010)

Nitric Oxide Levels in Patients with Psoriasis Treated with Methotrexate
por: Tekin, Nilgun Solak, et al.
Publicado: (2006)

A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
por: Srivastava, Divyanshu, et al.
Publicado: (2023)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Apremilast or Methotrexate: The Arrows in the Quiver for Psoriasis
por: Panda, Gautam, et al.
Publicado: (2023)

Efficacy and safety of methotrexate in alopecia areata
por: Hammerschmidt, Mariana, et al.
Publicado: (2014)

Efficacy of Vitamin E in Methotrexate-Induced Hepatotoxicity in Rheumatoid Arthritis: An Open-Label Case-Control Study
por: Vaidya, Binit, et al.
Publicado: (2020)

Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study
por: Habibi, Nastaran, et al.
Publicado: (2015)

Effects of co-treatment with pioglitazone and methotrexate on experimentally induced rheumatoid arthritis in Wistar albino rats
por: Roy, Tanushree, et al.
Publicado: (2017)

Long‐term safety of brodalumab in Japanese patients with plaque psoriasis: An open‐label extension study
por: Yamaguchi, Yukie, et al.
Publicado: (2020)

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
por: Ruperto, Nicolino, et al.
Publicado: (2009)

Comparative Effectiveness and Safety of Methotrexate Versus PUVA in Severe Chronic Stable Plaque Psoriasis
por: Banerjee, Saikat, et al.
Publicado: (2021)

Lifitegrast: A novel drug for treatment of dry eye disease
por: Abidi, Afroz, et al.
Publicado: (2016)

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
por: Vena, Gino Antonio, et al.
Publicado: (2018)

Nail psoriasis treated with intralesional methotrexate infiltration
por: Duarte, Artur Antônio, et al.
Publicado: (2019)

MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis
por: Zhu, Jie, et al.
Publicado: (2022)

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)
por: Saeki, Hidehisa, et al.
Publicado: (2016)

Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study
por: Sun, Rui, et al.
Publicado: (2023)

Efficacy and safety of pioglitazone in type 2 diabetes in the Indian patients: Results of an observational study
por: Balaji, Vijayam
Publicado: (2013)

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Real-world Efficacy and Safety of Apremilast Monotherapy in the Management of Moderate-to-severe Psoriasis
por: Shah, Bela J., et al.
Publicado: (2020)

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
por: Kim, Hae Jin, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Methotrexate versus Hydroxychloroquine in Preventing Lichen Planopilaris Progress: A Randomized Clinical Trial
por: Naeini, Farahnaz Fatemi, et al.
Publicado: (2017)

CSE-1034 versus Ceftriaxone: Efficacy and Safety Analysis from a Randomized, Open-labeled Phase III Study in Complicated Urinary Tract Infections
por: Chaudhary, Manu, et al.
Publicado: (2018)

Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension
por: Keystone, Edward, et al.
Publicado: (2014)

Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–assessor‐blinded clinical trial
por: Warren, R.B., et al.
Publicado: (2020)

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms
por: Warren, RB, et al.
Publicado: (2009)

The possibilities and principles of methotrexate treatment of psoriasis – the updated knowledge
por: Czarnecka-Operacz, Magdalena, et al.
Publicado: (2014)

Ulcerations due to methotrexate toxicity in a psoriasis patient
por: Souza, Claudia Fernanda Dias, et al.
Publicado: (2016)

Effects of methotrexate and etanercept treatment in moderate and severe psoriasis
por: Benites, Elizabeth, et al.
Publicado: (2022)

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma
por: Osminina, MK, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3s8dvbk4dascfl2rjjl8157cpl